Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Equus caballus | Ferritin light chain | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | Rap guanine nucleotide exchange factor (GEF) 4 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 43.9 % |
Echinococcus granulosus | expressed protein | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Schistosoma japonicum | Ferritin, putative | Ferritin light chain | 175 aa | 144 aa | 24.3 % |
Schistosoma mansoni | ferritin | Ferritin light chain | 175 aa | 171 aa | 44.4 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 146 aa | 28.8 % |
Echinococcus multilocularis | expressed protein | Ferritin light chain | 175 aa | 146 aa | 30.1 % |
Schistosoma mansoni | apoferritin-2 | Ferritin light chain | 175 aa | 142 aa | 29.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.3036 | 0.9521 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.1488 | 0.1468 |
Mycobacterium leprae | PROBABLE BACTERIOFERRITIN BFRA | 0.001 | 0 | 0.5 |
Echinococcus multilocularis | segment polarity protein dishevelled | 0.0011 | 0.0024 | 0.0074 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.3189 | 0.3173 |
Echinococcus granulosus | Pleckstrin G protein interacting region | 0.0011 | 0.0024 | 0.0074 |
Onchocerca volvulus | Rap guanine nucleotide exchange factor 1 homolog | 0.0218 | 1 | 1 |
Brugia malayi | RNA binding protein | 0.0076 | 0.3189 | 0.3173 |
Echinococcus multilocularis | Pleckstrin G protein, interacting region | 0.0011 | 0.0024 | 0.0074 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3189 | 1 |
Schistosoma mansoni | regulator of G protein signaling | 0.0011 | 0.0024 | 0.0074 |
Schistosoma mansoni | fyve finger-containing phosphoinositide kinase fyv1 | 0.0011 | 0.0024 | 0.0074 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.3036 | 0.9521 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.3036 | 1 |
Echinococcus granulosus | segment polarity protein dishevelled | 0.0011 | 0.0024 | 0.0074 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.3189 | 0.3173 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.3036 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3189 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.2405 | 0.2387 |
Schistosoma mansoni | dishevelled | 0.0011 | 0.0024 | 0.0074 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0424 | 0.0401 |
Echinococcus granulosus | segment polarity protein dishevelled | 0.0011 | 0.0024 | 0.0074 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3189 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3189 | 1 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.3036 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0424 | 0.133 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.3189 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.3036 | 1 |
Schistosoma mansoni | z-protein (S1r protein) | 0.0011 | 0.0024 | 0.0074 |
Schistosoma mansoni | dishevelled | 0.0011 | 0.0024 | 0.0074 |
Echinococcus multilocularis | regulator of G protein signaling 7 | 0.0011 | 0.0024 | 0.0074 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.2405 | 0.2387 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0424 | 0.0401 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.3189 | 0.3173 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0424 | 0.133 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0424 | 0.133 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.3189 | 0.3173 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0424 | 0.133 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.3036 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.2405 | 0.2387 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.3036 | 0.9521 |
Trichomonas vaginalis | ferritin, putative | 0.001 | 0 | 0.5 |
Schistosoma mansoni | dep domain containing protein | 0.0011 | 0.0024 | 0.0074 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.3189 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1488 | 0.1468 |
Echinococcus multilocularis | segment polarity protein dishevelled | 0.0011 | 0.0024 | 0.0074 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0424 | 0.133 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.3189 | 0.3173 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.3189 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0424 | 0.133 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0424 | 0.133 |
Wolbachia endosymbiont of Brugia malayi | bacterioferritin/cytochrome b1 | 0.001 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.2405 | 0.2387 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0424 | 0.133 |
Loa Loa (eye worm) | hypothetical protein | 0.0218 | 1 | 1 |
Echinococcus granulosus | regulator of G protein signaling 7 | 0.0011 | 0.0024 | 0.0074 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.3036 | 0.9521 |
Echinococcus granulosus | regulator of G protein signaling 7 | 0.0011 | 0.0024 | 0.0074 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0424 | 0.133 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0424 | 0.133 |
Echinococcus multilocularis | regulator of G protein signaling 7 | 0.0011 | 0.0024 | 0.0074 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0424 | 0.0401 |
Treponema pallidum | bacterioferrin (TpF1) | 0.001 | 0 | 0.5 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0424 | 0.0401 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.1488 | 0.4666 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.3036 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 19.9526 um | PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of Mitochondrial Division or Activators of Mitochondrial Fusion. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 75.6863 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Saccharomyces cerevisiae | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.